Predictive Value of Updating Framingham Risk Scores with Novel Risk Markers in the U.S. General Population
暂无分享,去创建一个
O. Franco | E. Steyerberg | M. Kavousi | M. Hunink | W. Max | B. Ferket | K. Fleischmann | M. Hunink | B. J. V. van Kempen | Isha Agarwal | O. Franco | B. J. van Kempen | M. Hunink
[1] Nancy R Cook,et al. A Bias-Corrected Net Reclassification Improvement for Clinical Subgroups , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[2] J. Gallacher,et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. , 2012, The New England journal of medicine.
[3] D. Goff,et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. , 2012, JAMA.
[4] Giel Nijpels,et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. , 2012, JAMA.
[5] Michael J Pencina,et al. Quantifying discrimination of Framingham risk functions with different survival C statistics , 2012, Statistics in medicine.
[6] A. Hofman,et al. Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification , 2012, Annals of Internal Medicine.
[7] D. Mozaffarian,et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.
[8] A. Elster. Comparative Effectiveness and Cost-Effectiveness of Computed Tomography Screening for Coronary Artery Calcium in Asymptomatic Individuals , 2012 .
[9] M. Pencina,et al. Ankle-brachial index and cardiovascular risk prediction: an analysis of 11,594 individuals with 10-year follow-up. , 2012, Atherosclerosis.
[10] S. Peters,et al. Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review , 2011, Heart.
[11] K. Nakashima,et al. [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.
[12] M. Arfan Ikram,et al. The Rotterdam Study: 2012 objectives and design update , 2011, European journal of epidemiology.
[13] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[14] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Circulation.
[15] Zahi A Fayad,et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2010, Journal of the American College of Cardiology.
[16] V. Aboyans,et al. The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis). , 2010, Journal of the American College of Cardiology.
[17] Ewout W Steyerberg,et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. , 2010, Journal of the American College of Cardiology.
[18] J. Danesh,et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis , 2010, The Lancet.
[19] Jeffrey L. Anderson,et al. ACCF / AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults , 2010 .
[20] Ersen B. Colkesen,et al. Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? , 2010, Archives of internal medicine.
[21] Barbara P. Yawn,et al. Using nontraditional risk factors in coronary heart disease risk assessment: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.
[22] Rongwei Fu,et al. Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.
[23] Michael J. Pencina,et al. Predicting the 30-Year Risk of Cardiovascular Disease: The Framingham Heart Study , 2009, Circulation.
[24] C. Choi,et al. Estimating the probability of stroke in Korean hypertensive patients visiting tertiary hospitals using a risk profile from the framingham study , 2009, BMC neurology.
[25] L. Smeeth,et al. Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. , 2009, International journal of epidemiology.
[26] Monique M. B. Breteler,et al. The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.
[27] N. Paynter,et al. C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men , 2008, Circulation.
[28] A Hofman,et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. , 2008, JAMA.
[29] Moyses Szklo,et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). , 2008, Archives of internal medicine.
[30] M. Pencina,et al. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.
[31] Lawrence A Leiter,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines , 2006, Current opinion in cardiology.
[32] Warren J Manning,et al. ACCF/AHA clinical competence statement on cardiac imaging with computed tomography and magnetic resonance: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. , 2005, Journal of the American College of Cardiology.
[33] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[34] T J Ulahannan,et al. Decision Making in Health and Medicine: Integrating Evidence and Values , 2002 .
[35] S M Grundy,et al. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. , 2001, Circulation.
[36] R. D'Agostino,et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. , 2001, JAMA.
[37] M. Bayes,et al. The Probability of , 2001 .
[38] N. Wald,et al. When can a risk factor be used as a worthwhile screening test? , 1999, BMJ.
[39] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.
[40] R B D'Agostino,et al. Probability of stroke: a risk profile from the Framingham Study. , 1991, Stroke.